GlassScriptPhysician profile
Allison P Warren
NPI 1548592447
$2,195.78
in general payments reported to CMS, 2019-2025
33 companies · $427 in 2025
The $427 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $183 · 2021: $439 · 2022: $197 · 2023: $369 · 2024: $252 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $882.59 |
| Education | $164.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $287.20 | 2019-2024 | |
| Astellas Pharma US INC | $281.24 | 2023-2025 | Veozah, Myrbetriq |
| Sage Therapeutics, LLC | $162.78 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $144.69 | 2021-2025 | |
| Exeltis, USA INC. | $133.97 | 2020-2024 | |
| Daiichi Sankyo INC. | $107.97 | 2019-2021 | |
| Lupin INC. | $103.42 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $90.98 | 2019-2023 | Gardasil 9 |
| Therapeuticsmd, INC. | $79.55 | 2019 | |
| Shield Therapeutics INC | $75.44 | 2024-2025 | |
| Channel Medsystems, INC. | $70.90 | 2022 | |
| Boston Scientific Corporation | $69.63 | 2025 | Solyx Sis System, Bulkamid - Bulkamid Urethral Bulking Pack 2ml (Ous) |
| Aspira Women'S Health INC | $66.60 | 2021 | |
| Pfizer INC. | $59.94 | 2019-2023 | |
| Organon LLC | $50.57 | 2021-2025 | Nexplanon |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $45.40 | 2025 | Qelbree |
| Sumitomo Pharma America, INC. | $42.73 | 2023-2025 | Gemtesa, Myfembree |
| Axonics, INC. | $37.04 | 2023 | Axonics, Bulkamid |
| Horizon Therapeutics Plc | $35.61 | 2019-2021 | |
| Allergan, INC. | $29.66 | 2022 | |
| Mylan Pharmaceuticals INC. | $24.80 | 2021-2022 | |
| Medtronic, INC. | $23.96 | 2024 | Interstim |
| Abbott Laboratories | $20.40 | 2025 | Ensite |
| Mission Pharmacal Company | $19.44 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.41 | 2023 | |
| Monaghan Medical Corporation | $18.28 | 2023 | Aerochamber |
| Coopersurgical, INC. | $15.56 | 2025 | Paragard T 380a |
| Exact Sciences Corporation | $14.84 | 2023 | Cologuard Collection Kit |
| Agile Therapeutics, INC. | $14.29 | 2021 | |
| Hologic Sales and Service, LLC | $13.88 | 2020 | |
| Medicem INC. | $13.22 | 2021 | |
| Myovant Sciences INC. | $12.18 | 2021 | |
| Novo Nordisk INC | $11.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Warren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.